Neoplasia/BPH

	A systematic review and meta-analysis of clinicopathologic factors associated with adverse oncologic outcomes in bladder cancer patients undergoing radical cystectomy: Evidence from multivariable survival prediction models. Urol Oncol Artiles Medina A, Subiela JD, Muriel García A, Domínguez Gutiérrez A, Gómez Dos Santos V, Álvarez Díaz N, Tagalos Muñoz A, López Curtis D, Mínguez Ojeda C, de la Parra Sánchez I, Crespo L, Coloma Del Peso A, Burgos Revilla FJ. PMID: 42086443 [PubMed - as supplied by publisher]
	Genetic evidence against a causal relationship between myocardial infarction and urological malignancies. Can J Urol Zhang W, Peng X. PMID: 42086356 [PubMed - indexed for MEDLINE]
	Virtual basket mode in HoLEP: reduced early dysuria and faster continence recovery without loss of efficacy. Can J Urol Özcan S, Dama M, Yorulmaz EM, Köse O, Görgel SN, Ak. PMID: 42086355 [PubMed - indexed for MEDLINE]
	Analysis of risk factors for MRI-invisible prostate cancer-the significance of AGGF1 immunohistochemical detection and PSAD. Can J Urol Lyu J, Yue R, Tian Y, Yang B. PMID: 42086354 [PubMed - indexed for MEDLINE]
	Bladder cancer patients hospitalized in a medicine ward including three fuo cases following bacillus calmette-guÃ©rin immunotherapy. Can J Urol Liatsos G, Zioutou K, Avramidis K, Vamvakaris K, Potamiti-Komi M, Vassilopoulos D. PMID: 42086353 [PubMed - indexed for MEDLINE]
	Genetic evidence for associations between food intake and prostatic diseases: a Mendelian randomization study. Can J Urol Chen X, Ren C, Xie L, Liu X. PMID: 42086352 [PubMed - indexed for MEDLINE]
	Overweight status predicts improved overall survival after radical nephroureterectomy for upper tract urothelial carcinoma. Can J Urol Wu SY, Li CC, Wu WJ, Huang KH, Liu CL, Wang SS, Li JR, Weng HY, Tai TY, Chen PC, Cheong IS, Tsai CY, Cheng PY, Hong JH, Chen CH, Tseng JS, Lin WR, Jiang YH, Lee YK, Lin PH, Pang ST, Chen YT, Chen WC, Wu CC, Hsueh TY, Huang HC, Lin WY, Yu CC, Fang JK, Yu CC, Tsai YC. PMID: 42086351 [PubMed - indexed for MEDLINE]
	Urodynamic de-obstruction and symptom improvement after thulium laser vaporization (ThuVAP): evidence from a prospective paired study. Can J Urol Tammaro S, Di Fiore F, Crocetto F, Manfredi C, Ruvolo CC, Califano G, Barone B, Arcaniolo D, Spirito L, Calace FP, Reccia P, Fusco F, De Sio M, Balsamo R. PMID: 42086345 [PubMed - indexed for MEDLINE]
	Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinoma. J Immunother Cancer Govindarajan A, Hansen N, Mercier BD, Byron SA, Hegde A, Garcia-Mansfield K, Leskoske K, Chawla N, Meza L, Zengin Z, Barragan-Carillo R, Ebrahimi H, Castro DV, Dizman N, Hsu J, Chehrazi-Raffle A, Tripathi A, Salgia NJ, Pal SK, Pirrotte P. PMID: 42086309 [PubMed - indexed for MEDLINE]
	Integrating the relevance of sleep into testicular-cancer survivorship care. Support Care Cancer Toricelli M, Alvarenga TA, Porcacchia AS, Tufik S, Andersen ML. PMID: 42084766 [PubMed - indexed for MEDLINE]
	The relationship between proteins of the mismatch repair system and the prognosis of prostate cancer: A systematic review. Genet Mol Biol Silva KS, Pasotti MCDP, Souza LGNR, Leite KRM, Reis ST. PMID: 42084453 [PubMed]
	Clinical Relevance of Biomarkers in Prostate Cancer: The Role of NKX3.1, AMACR, and Ki-67 in Risk Stratification - A Comprehensive Clinicopathological Analysis. Chirurgia (Bucur) Ro, Enciu M, A, Ionescu CA, Pundiche M, Dobrin N, , Nicolau AA, Nicoleta L, Caraban B, Deacu S, B, Bulbuc I, Popovici IA, Petcu LC. PMID: 42084251 [PubMed - indexed for MEDLINE]
	Targeting Human Epidermal Growth Factor Receptor 2 in Bladder Cancer: Evaluating Its Role as a More Robust Clinicopathological Biomarker Compared to Programmed Death Ligand 1 Expression. Urol Res Pract Mittal A, Malhotra K, Panwar V, Kishore S, Taher M, Singhal A. PMID: 42083993 [PubMed]
	The Experiences and Perspective of Partners of Men With Prostate Cancer in Ireland: A Qualitative Descriptive Study. Nurs Open Mumuni S, O'Donnell C, Doody O. PMID: 42083831 [PubMed - indexed for MEDLINE]
	Automatic Recognition Algorithm for Renal Tumors and Cysts in CT Images using Mamba and YOLO11. Curr Med Imaging Jiali J, Zhaoxue C. PMID: 42083523 [PubMed - as supplied by publisher]
	Exceptional and typical biomarker responses to AminoTriComplex in metastatic prostate cancer: a case series. J Med Case Rep Tavartkiladze A, Simonia G, Reiter RJ, Lou R, Okrostsvaridze N, Kasradze D, Revazishvili P, Andronikashvili I, Nozadze P, Tavartkiladze G, Khutsishvili R, Potskhoraia T. PMID: 42083014 [PubMed - as supplied by publisher]
	Explainable and visualizable machine learning model development and validation for 5-year postoperative survival prediction in prostate cancer patients agedâ€‰â‰¥â€‰65 years. BMC Geriatr Cheng H, Shen T. PMID: 42082925 [PubMed - as supplied by publisher]
	Racial Disparities in Shared Decision Making Among Prostate Cancer Patients: A National Study. J Racial Ethn Health Disparities Daggolu J, Khalid J, Aparasu RR. PMID: 42082839 [PubMed - as supplied by publisher]
	Adaptive Knowledge Distillation for Anatomical Segmentation in Pelvic CT Imaging of Prostate Cancer. Ann Biomed Eng Karata, Demir B, Kaya A, Özkan E, Küçük NÖ. PMID: 42082797 [PubMed - as supplied by publisher]
	Multimodal deep learning model for multiclass classification of renal tumors. NPJ Digit Med Luo S, Quan Q, Yang R, Li C, Yao J, Tang F, Wang Y, Zhou KS, Liu J. PMID: 42082763 [PubMed - as supplied by publisher]

Articles 1 - 20 / 187595

Page 1 of 9380



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy